What Giuliani does

Giuliani S.p.A. is a privately-held, family-owned Italian pharmaceutical company founded in Milan in 1889, specializing in gastroenterology, dermatology, and trichology. The company manufactures and sells a broad portfolio spanning prescription and OTC pharmaceuticals, dermocosmetics, and dietary supplements, marketed under multiple category-leading brands including Bioscalin (#1 hair brand in Italy for over 25 years), Trosyd, Lichtena, MonoDermà, Kerà, Psyllogel, Armonia, Tricovel, Milice, Inlevia, and the Biogena portfolio acquired in 2023. Its R&D base comprises 761 granted patents globally (636 in Europe, 125 rest of world) plus 112 under assessment, with proprietary technologies including the iSFRP-1 hair-loss molecule, BIOSCALIN iON delivery technology, MonoDermoDose single-dose packaging, and pre/pro/postbiotic microbiome formulations.

The company's business model combines branded consumer health products distributed primarily through pharmacies with a direct medical-scientific sales force targeting dermatologists and pharmacists. Revenue is generated across three principal streams — pharmaceuticals, dermocosmetics, and nutraceuticals — sold predominantly as one-time unit purchases through the pharmacy channel in Italy, with direct subsidiary operations and distributor partnerships extending reach to more than 12 countries including France, Belgium, Portugal, Spain, Germany, Switzerland, Turkey, Greece, Slovakia, Hong Kong, and Mexico. Strategic acquisitions are central to the growth model: Nathura (March 2021) added the Psyllogel and Armonia platforms, Biogena (January 2023) added the Osmin/Mellis/Inosit/Laris/Bioliftan dermatology line, and Laboratoires Bailleul (October 2025) added a pan-European dermatology/trichology/gynecology platform that management expects to drive consolidated turnover to approximately €250M by 2026.

Giuliani monetizes through retail pharmacy sell-through, supplemented by brand-specific e-commerce portals and event-driven demand activation (notably the Cosmofarma exhibition channel). R&D intensity is concentrated in trichology (>300 patents), microbiome science, and dermatology, with clinical evidence programs supporting premium positioning. Ownership remains concentrated in the Giuliani family, with Giammaria Giuliani on the Board of Directors and Gaetano Colabucci as CEO/General Manager leading professional management. The company has no external private equity or venture capital ownership disclosed.

Name

Giuliani

Legal name

Giuliani S.p.A.

Website

https://giulianipharma.com

Company type

Private

Founded year

1889

Operating status

Operating

Headcount range

101–250 employees

Short description

Giuliani is a privately-held, family-owned Italian pharmaceutical company founded in 1889 that develops and markets OTC pharmaceuticals, dermocosmetics, and nutraceuticals in gastroenterology, dermatology, and trichology, distributed through pharmacies across Italy and 12+ countries, with Bioscalin as Italy's #1 hair brand.

Ownership category

akta.pro rank

Product category

Specialty Pharmaceuticals (Dermatology and Trichology)

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Pharmaceutical Preparations (2834), Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

akta.pro secondary industries

Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Dermatology & Topical Skin Treatments (HLAIADAE), Sleep, Stress & Mood Support (HLAIADAG)

Keywords

• Dermatology pharmaceuticals
• Trichology hair care
• Dermocosmetic formulations
• Gastroenterology supplements
• OTC pharmaceuticals

Headquarters

HQ city

Milano

HQ country

Italy

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Pharmaceutical Products: Giuliani manufactures and sells prescription and OTC pharmaceutical products for dermatological conditions, nail disorders, intimate health, and gastrointestinal problems through pharmacies.
2. Dermocosmetics: Sale of dermocosmetic products including hair care (Bioscalin, Tricovel), skin care (Lichtena, MonoDermà, Kerà), and intimate care products through pharmacies and direct-to-consumer e-commerce.
3. Nutraceuticals/Dietary Supplements: Sale of dietary supplements including Psyllogel (intestinal health), Armonia (sleep wellness with melatonin), Bioscalin supplements, and Trixy (metabolic health) through pharmacies.
4. International Markets: Revenue from international expansion through acquisitions (Bailleul) and direct operations in multiple countries including France, Italy, Belgium, Portugal, Spain, Germany, Switzerland, Turkey, Greece, Slovakia, Hong Kong, and Mexico.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Core offering

Giuliani manufactures and markets prescription and OTC pharmaceutical products, dermocosmetics, and dietary supplements across dermatology, trichology, gastroenterology, gynecology, and sleep wellness. The portfolio is organized into brand lines such as Bioscalin (hair care), Tricovel (hair supplements), Lichtena (sensitive skin), MonoDermà (vitamin dermocosmetics), Kerà, Trosyd, Primak, Psyllogel (intestinal health), Armonia (melatonin-based sleep), and Inlevia (intimate care), sold primarily through pharmacies and brand websites in Italy and abroad.

Product overview

Giuliani is a 100% Italian pharmaceutical company founded in 1889, operating through multiple product lines spanning dermatology, trichology, gastroenterology, and gynecological care. The portfolio includes core hair care brands (Bioscalin, Tricovel, Milice), dermatological brands (Lichtena, MonoDermà, Kerà, Nidrox, Salax, Primak), gastrointestinal products (Amaro Giuliani, Psyllogel, Eucarbon, Trixy), sleep wellness (Armonia), gynecological products (Inlevia, Celevis Plus, Celegyn), and skin/nail treatments (Trosyd). The company has expanded through acquisitions including Nathura (2021, Psyllogel and Armonia brands), Biogena (2023), and Laboratoires Bailleul (2025, expected €250M turnover in 2026). Products range from OTC medications and medical devices to dietary supplements and dermocosmetics.

Differentiator

Problem solved

Functional benefit

Brands

• Bioscalin: Hair care line including anti-hair loss treatments, supplements, shampoos, and hair coloring products. Number 1 hair brand in Italy for over 25 years.
• Trosyd
• Lichtena
• Milice
• Tricovel
• Armonia
• Psyllogel
• MonoDermà
• Kerà
• Inlevia
• Celevis Plus
• Primak
• Nidrox
• Amaro Giuliani Elisir di Benessere

Products and services

• Bioscalin hair care line Bioscalin is Giuliani's flagship hair care brand offering anti-hair loss supplements, ampoules, shampoos, conditioners, and hair color products for men and women. The line addresses hair loss, thinning, weakened hair, scalp microbiome imbalance, and menopause- or stress-related hair changes using patented technologies such as iSFRP-1 molecule and BIOSCALIN iON TECHNOLOGY. It is the #1 hair brand in Italy.
• Tricovel specialist hair care line Tricovel is a specialist hair care line featuring patented active ingredient combinations including Spermidine, Ajuga reptans extract, omega-6/omega-9 fatty acids, and Rutin. The line comprises dietary supplements, a spray lotion, PRP Plus gel products, and a postbiotic shampoo for hair trophism and anti-thinning needs.
• Trosyd skin, nail, and intimate care line Trosyd is a pharmaceutical line covering antifungal treatments, nail disorder products, wound repair cream, gynecological ovuli for vulvovaginal fungal infections, and a 2% shampoo for seborrheic dermatitis and dandruff. Products are sold OTC through pharmacies.
• Lichtena sensitive and atopy-prone skin line Lichtena is a face and body care line for irritated, sensitive, and atopy-prone skin in adults and children, built around the Octa-BEE complex. The range includes the DermAD line for atopy-prone skin, Lenixer restorative cream, and pediatric products, sold through pharmacies.
• MonoDermà vitamin dermocosmetic line MonoDermà is a minimalist dermocosmetic line offering pure vitamins (C10, E5, A15 retinol, ProEtas supplement, and the ET10 XL medical device) in single-dose biodegradable gel packs via the proprietary MonoDermoDose technology. The line targets consumers seeking preservative-free, single-dose vitamin skincare.
• Kerà skin and scalp care line Kerà is a Giuliani skin treatment line featuring K1 and K2 treatment creams, Mucose lipogel for cheilitis, Scalpo Danno Zero scalp spray, and SPF 50+ sun protection fluids and sticks, sold through pharmacies.
• Primak probiotic skin line Primak is a probiotic- and postbiotic-based line for acne-prone and blemish-prone skin, including cleanser, dietary supplement, DIAKON treatment products, MED gel, and BODY spray.
• Armonia melatonin sleep wellness line Armonia is a sleep wellness line of 99% pure melatonin supplements including Armonia Fast, Fast Orosolubile, Rilascio Controllato, and Relax variants for sleep onset, jet lag, and mood support. Sold through pharmacies.
• Psyllogel intestinal health line Psyllogel is a natural dietary supplement line for intestinal wellness, including Psyllogel Fibra (psyllium fiber), Psyllogel Fast (with lactitol), Psyllogel Gonfiore (for abdominal bloating), and Psyllogel Megafermenti (probiotics), positioned as a leader in the Italian laxative fiber segment.
• Inlevia intimate care line Inlevia is Giuliani's intimate care line including Inlevia Gyno Cream, Inlevia Defence barrier cream, and Inlevia Gyno Mousse cleansing mousse, aimed at supporting vulvar and vaginal ecosystem balance.
• Milice anti-lice program Milice is Giuliani's complete anti-lice program, including PidoKO treatments for eliminating head lice and nits, the Combylice diagnostic comb, and complementary products, sold through pharmacies.
• Amaro Giuliani Elisir di Benessere Amaro Giuliani Elisir di Benessere is an oral digestive solution containing extracts of Boldo, Gentian, Pomegranate, and Artichoke that supports the gastrointestinal tract and intestinal microbiota balance. It is the company's heritage product dating to 1889.
• Eucarbon R.I. digestive supplement Eucarbon R.I. is a plant-based dietary supplement promoting gas absorption and elimination with a calming effect on the abdomen, useful for symptoms of irritable bowel. Sold through pharmacies.
• Trixy metabolic health supplement Trixy is a Giuliani dietary supplement combining Berberis aristata, green coffee extract, and tocotrienols to support balanced metabolism, liver function, cardiovascular health, and fluid drainage.
• Biogena dermatological product portfolio Biogena is Giuliani's acquired dermatological product portfolio including Osmin, Mellis, Inosit, Laris, and Bioliftan brands for therapeutic skin products, hair treatments, cleansers, deodorants, and sun care, sold through pharmacies.

Quantifiable outcome

• 75% stronger hair in 15 days (Bioscalin Nova-Genina clinical study)
• +3 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered core, minor and strategic.

• Laboratoires BailleulcoreStrategic or Co-development Partner · 7 October 2025Giuliani acquired Laboratoires Bailleul, a French company specialized in dermatology, trichology, and gynecology. The acquisition strengthens Giuliani's presence in hair and skin care sectors and is expected to bring turnover to approximately €250 million by 2026. Bailleul operates directly in France, Italy, Belgium, Portugal, Spain, Germany, Switzerland, Turkey, Greece, Slovakia, with hubs in Hong Kong and Mexico.
• Valetudo (Biogena Line)coreStrategic or Co-development Partner · 13 January 2023Giuliani acquired the Biogena dermatological product portfolio from Valetudo, a company based in Bergamo founded in 1982. Biogena offers therapeutic skin products, hair treatments, cleansers, deodorants, and sun care products with leading brands including Osmin, Mellis, Inosit, Laris, and Bioliftan. Valetudo continues as manufacturer through multi-year supply agreement.
• Nathura SpAcoreStrategic or Co-development Partner · 30 March 2021Giuliani acquired Nathura SpA, specializing in nutraceuticals and leader in laxative fiber segment (Psyllogel brand) and sleep products segment (Armonia brand). Based in Montecchio (Reggio Emilia), Nathura had 2020 turnover of over €14 million and EBITDA margin of more than 30%, with about 60 employees. This acquisition strengthened Giuliani's gastrointestinal business.
• Giovannelli e AssociatiminorOthers · 30 March 2021Legal advisors for Nathura acquisition.
• Fondazione Milan / AC MilanminorGTM or Marketing PartnerBioscalin partnered with Fondazione Milan as Match Sponsor for AC Milan matches, supporting the Sport4All project to promote sporting activity for people with disabilities. Green wigs distributed to fans with donations made to the foundation for each wig worn.
• A. Gemelli University Hospital (Rome)strategicStrategic or Co-development PartnerGiuliani and Fondazione Policlinico Universitario Agostino Gemelli in Rome partnered to promote personalized Nutritional Therapy, combining Giuliani's nutraceutical expertise with the hospital's medical research capabilities.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Pierre Fabre: French family-owned pharmaceutical and dermo-cosmetic group with Avène, Ducray, A-Derma and René Furterer brands distributed primarily through pharmacies across Europe. Highly comparable to Giuliani in pharmacy-channel dermo-cosmetics, dermatology focus, family ownership, and mid-cap European footprint.
• Aboca: Italian family-owned herbal pharmaceutical company specializing in natural OTC, nutraceuticals, and medical devices for gastro, respiratory and skin care, sold through pharmacies. Closest Italian comparable to Giuliani in heritage, family ownership, pharmacy channel, and OTC nutraceutical/pharma mix.
• NAOS (Bioderma): French privately-owned dermo-cosmetic group behind Bioderma, Institut Esthederm and Etat Pur brands, distributed primarily through pharmacies and dermatologists. Directly comparable to Giuliani on dermo-skincare positioning, pharmacy channel, and French/European geographic footprint.
• Laboratoires Expanscience: French family-owned pharmaceutical and dermo-cosmetic company (Mustela, Aderma, Densifique) with OTC dermatology and pregnancy-care products sold through pharmacies. Comparable to Giuliani in mid-cap family-owned dermo-cosmetic, dermatology focus, and pharmacy-led distribution.
• Pileje: French privately-held nutraceutical and microbiome health company selling dietary supplements and OTC products through pharmacies and healthcare professionals. Directly comparable to Giuliani's Psyllogel/Armonia/Trixy nutraceutical franchise, especially in gut-brain-sleep wellness.

Broad incumbents

• Recordati: Italian specialty pharmaceutical group with strong dermatology, gastroenterology and rare disease franchises (including OTC heritage via Proctolin, Mirful). Larger public peer (€2B+ revenue) sharing Giuliani's historical Italian pharma identity and therapeutic focus areas.
• Menarini: Italian privately-owned pharmaceutical group with dermatology, gastroenterology, and consumer health OTC portfolio across Europe. Larger incumbent sharing Giuliani's pharmacy distribution heritage and Italian pharma identity (also commemorated alongside Giuliani in 2026 stamp).
• Beiersdorf (Eucerin): Global consumer goods company whose Eucerin and Hansaplast/Elastoplast brands are leading dermo-skincare and OTC dermatology lines sold through pharmacies. Broader incumbent competitor to Giuliani in pharmacy-channel dermatology, with much larger R&D and marketing scale.
• La Roche-Posay (L'Oréal): Global dermocosmetics brand owned by L'Oréal, sold primarily through pharmacies and dermatologists. Competes directly with Giuliani's Lichtena, MonoDermà and Kerà lines in medical-grade skincare and represents the scale benchmark Giuliani is measured against.
• Chiesi Farmaceutici: Italian family-owned specialty pharmaceutical group with gastroenterology, dermatology and rare disease focus. Comparable as a larger Italian family pharma peer sharing Giuliani's therapeutic emphasis and Italian heritage, though more prescription-leaning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/GiulianiPharma
• YouTubeyoutube.com/@giulianipharma
• Instagraminstagram.com/giulianipharma

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Giuliani